MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China)

References

• Vanittanakom N, Cooper CR Jr., Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95–110. doi:10.1128/CMR.19.1.95-110.2006
   PubMed Web of Science ®Google Scholar
• Peng J, Chen Z, Cai R, et al. Recovery from Talaromyces marneffei involving the kidney in a renal transplant recipient: a case report and literature review. Transpl Infect Dis. 2017;19(4):e12710. doi:10.1111/tid.12710
   Web of Science ®Google Scholar
• Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5:e19. doi:10.1038/emi.2016.18
   PubMed Web of Science ®Google Scholar
• Kawila R, Chaiwarith R, Supparatpinyo K. Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study. BMC Infect Dis. 2013;13(1):464. doi:10.1186/1471-2334-13-464
   Web of Science ®Google Scholar
• Lang Q, Pasheed Chughtai A, Kong WF, Yan HY. Case report: successful treatment of pulmonary Talaromyces marneffei infection with posaconazole in a renal transplant recipient. Am J Trop Med Hyg. 2020;104(2):744–747. doi:10.4269/ajtmh.20-0909
   Web of Science ®Google Scholar
• Chi XH, Xue YM, Wang QS, Li GP, Zhou HS, Qi YS. Diagnosis and treatment of diffusible Penicillium marneffei in human immunodeficiency virus-negative patients: a challenge for the physician. Indian J Med Microbiol. 2017;35(4):617–619. doi:10.4103/ijmm.IJMM_15_418
   Web of Science ®Google Scholar
• Lau SK, Lam CS, Ngan AH, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for rapid identification of mold and yeast cultures of Penicillium marneffei. BMC Microbiol. 2016;16:36. doi:10.1186/s12866-016-0656-0
   PubMed Web of Science ®Google Scholar
• Sun Y, Guo J, Chen R, et al. Multicenter evaluation of three different MALDI-TOF MS systems for identification of clinically relevant filamentous fungi. Med Mycol. 2021;59(1):81–86. doi:10.1093/mmy/myaa037
   Web of Science ®Google Scholar
• Seyfarth F, Wiegand C, Erhard M, Graser Y, Elsner P, Hipler UC. Identification of yeast isolated from dermatological patients by MALDI-TOF mass spectrometry. Mycoses. 2012;55(3):276–280. doi:10.1111/j.1439-0507.2011.02086.x
   Web of Science ®Google Scholar
• Fang L, Xu H, Ren X, et al. Epidemiology and risk factors for carbapenem-resistant Klebsiella pneumoniae and subsequent MALDI-TOF MS as a tool to cluster KPC-2-producing Klebsiella pneumoniae, a retrospective study. Front Cell Infect Microbiol. 2020;10:462. doi:10.3389/fcimb.2020.00462
   Web of Science ®Google Scholar
• Dhieb C, Normand AC, Al-Yasiri M, et al. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata. Med Mycol. 2015;53(5):462–469. doi:10.1093/mmy/myv013
   Web of Science ®Google Scholar
• Usbeck JC, Wilde C, Bertrand D, Behr J, Vogel RF. Wine yeast typing by MALDI-TOF MS. Appl Microbiol Biotechnol. 2014;98(8):3737–3752. doi:10.1007/s00253-014-5586-x
   Web of Science ®Google Scholar
• Bartosch T, Heydel T, Uhrlass S, et al. MALDI-TOF MS analysis of bovine and zoonotic Trichophyton verrucosum isolates reveals a distinct peak and cluster formation of a subgroup with Trichophyton benhamiae. Med Mycol. 2018;56(5):602–609. doi:10.1093/mmy/myx084
   Web of Science ®Google Scholar
• Yu K, Huang Z, Li Y, et al. Establishment and application of matrix-assisted laser desorption/Ionization time-of-flight mass spectrometry for detection of Shewanella genus. Front Microbiol. 2021;12:625821. doi:10.3389/fmicb.2021.625821
   PubMed Web of Science ®Google Scholar
• Lei HL, Li LH, Chen WS, et al. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. Eur J Clin Microbiol Infect Dis. 2018;37(6):1099–1102. doi:10.1007/s10096-018-3222-x
   PubMed Web of Science ®Google Scholar
• Wong SS, Ho TY, Ngan AH, Woo PC, Que TL, Yuen KY. Biotyping of Penicillium marneffei reveals concentration-dependent growth inhibition by galactose. J Clin Microbiol. 2001;39(4):1416–1421. doi:10.1128/JCM.39.4.1416-1421.2001
   Web of Science ®Google Scholar
• Samson RA, Yilmaz N, Houbraken J, et al. Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud Mycol. 2011;70(1):159–183. doi:10.3114/sim.2011.70.04
   PubMed Web of Science ®Google Scholar
• Li HR, Cai SX, Chen YS, et al. Comparison of Talaromyces marneffei infection in human immunodeficiency virus-positive and human immunodeficiency virus-negative patients from Fujian, China. Chin Med J. 2016;129(9):1059–1065. doi:10.4103/0366-6999.180520
   Web of Science ®Google Scholar
• Wang YG, Cheng JM, Ding HB, et al. Study on the clinical features and prognosis of Penicilliosis marneffei without human immunodeficiency virus infection. Mycopathologia. 2018;183(3):551–558. doi:10.1007/s11046-017-0236-3
   Web of Science ®Google Scholar
• Wang HC, Hsieh MI, Choi PC, Wu CJ. Comparison of the sensititre YeastOne and CLSI M38-A2 microdilution methods in determining the activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species. J Clin Microbiol. 2018;56(10). doi:10.1128/JCM.00780-18
   Web of Science ®Google Scholar
• Wang H-C, Hsieh M-I, Choi P-C, Wu C-J. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species. Mycology. 2018;56(10):e00780–18.
   Google Scholar
• Guinea J, Pelaez T, Alcala L, Bouza E. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2006;56(1):53–55. doi:10.1016/j.diagmicrobio.2006.03.004
   Web of Science ®Google Scholar
• Delma FZ, Al-Hatmi AMS, Buil JB, et al. Comparison of MIC test strip and sensititre YeastOne with the CLSI and EUCAST broth microdilution reference methods for in vitro antifungal susceptibility testing of Cryptococcus neoformans. Antimicrob Agents Chemother. 2020;64(4). doi:10.1128/AAC.02261-19
   Web of Science ®Google Scholar
• Sar B, Boy S, Keo C, et al. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia. J Clin Microbiol. 2006;44(11):4208–4210. doi:10.1128/JCM.00902-06
   PubMed Web of Science ®Google Scholar
• Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M. In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother. 2003;47(4):1376–1381. doi:10.1128/AAC.47.4.1376-1381.2003
   PubMed Web of Science ®Google Scholar
• Hohl TM. Overview of vertebrate animal models of fungal infection. J Immunol Methods. 2014;410:100–112. doi:10.1016/j.jim.2014.03.022
   PubMed Web of Science ®Google Scholar
• Boyce KJ, Andrianopoulos A. Fungal dimorphism: the switch from hyphae to yeast is a specialized morphogenetic adaptation allowing colonization of a host. FEMS Microbiol Rev. 2015;39(6):797–811. doi:10.1093/femsre/fuv035
   PubMed Web of Science ®Google Scholar
• Alexander BD, Procop GW, Dufresne P, et al. M27 reference method for broth dilution antifungal susceptibility testing of yeasts. Clinical and Laboratory Standards Institute; 2017. ( M27, 4th ed).
   Google Scholar
• Lau SKP, Xing F, Tsang CC, et al. Clinical characteristics, rapid identification, molecular epidemiology and antifungal susceptibilities of Talaromyces marneffei infections in Shenzhen, China. Mycoses. 2019;62(5):450–457. doi:10.1111/myc.12887
   Web of Science ®Google Scholar
• Lau SK, Lo GC, Lam CS, et al. In vitro activity of posaconazole against talaromyces marneffei by broth microdilution and Etest methods and comparison to Itraconazole, Voriconazole, and Anidulafungin. Antimicrob Agents Chemother. 2017;61(3). doi:10.1128/AAC.01480-16
   Web of Science ®Google Scholar
• Filiotou A, Giannaris M, Kaloterakis A, et al. First case of Penicillium marneffei fungemia in Greece and strain susceptibility to five licensed systemic antifungal agents and posaconazole. Am J Med Sci. 2006;332(1):43–45. doi:10.1097/00000441-200607000-00009
   Web of Science ®Google Scholar
• Liu D, Liang L, Chen J. In vitro antifungal drug susceptibilities of Penicillium marneffei from China. J Infect Chemother. 2013;19(4):776–778. doi:10.1007/s10156-012-0511-7
   Web of Science ®Google Scholar
• Yilmaz N, Visagie CM, Houbraken J, Frisvad JC, Samson RA. Polyphasic taxonomy of the genus Talaromyces. Stud Mycol. 2014;78:175–341.
   Google Scholar